These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38203716)

  • 1. Proof-of-Concept Study on the Use of Tangerine-Derived Nanovesicles as siRNA Delivery Vehicles toward Colorectal Cancer Cell Line SW480.
    Rabienezhad Ganji N; Urzì O; Tinnirello V; Costanzo E; Polito G; Palumbo Piccionello A; Manno M; Raccosta S; Gallo A; Lo Pinto M; Calligaris M; Scilabra SD; Di Bella MA; Conigliaro A; Fontana S; Raimondo S; Alessandro R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
    Lamichhane TN; Jay SM
    Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene knockdown in HaCaT cells by small interfering RNAs entrapped in grapefruit-derived extracellular vesicles using a microfluidic device.
    Itakura S; Shohji A; Amagai S; Kitamura M; Takayama K; Sugibayashi K; Todo H
    Sci Rep; 2023 Feb; 13(1):3102. PubMed ID: 36813850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour-homing and intracellular freeway transportation.
    Zhou X; Miao Y; Wang Y; He S; Guo L; Mao J; Chen M; Yang Y; Zhang X; Gan Y
    J Extracell Vesicles; 2022 Mar; 11(3):e12198. PubMed ID: 35233952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
    O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
    Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
    Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
    Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic siRNA Loading of Extracellular Vesicles Enables Functional Delivery into Cells.
    Roerig J; Mitrach F; Schmid M; Hause G; Hacker MC; Wölk C; Schulz-Siegmund M
    Small Methods; 2022 Dec; 6(12):e2201001. PubMed ID: 36284470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.
    Kooijmans SAA; Stremersch S; Braeckmans K; de Smedt SC; Hendrix A; Wood MJA; Schiffelers RM; Raemdonck K; Vader P
    J Control Release; 2013 Nov; 172(1):229-238. PubMed ID: 23994516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phospholipase DDHD1 as a new target in colorectal cancer therapy.
    Raimondo S; Cristaldi M; Fontana S; Saieva L; Monteleone F; Calabrese G; Giavaresi G; Parenti R; Alessandro R
    J Exp Clin Cancer Res; 2018 Apr; 37(1):82. PubMed ID: 29653539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loading of "cocktail siRNAs" into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer.
    Diao Y; Wang G; Zhu B; Li Z; Wang S; Yu L; Li R; Fan W; Zhang Y; Zhou L; Yang L; Hao X; Liu J
    Cancer Biol Ther; 2022 Dec; 23(1):163-172. PubMed ID: 35171081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Biocargo and Anti-Inflammatory Effect of Tomato Fruit-Derived Nanovesicles Separated by Density Gradient Ultracentrifugation and Loaded with Curcumin.
    Mammadova R; Maggio S; Fiume I; Bokka R; Moubarak M; Gellén G; Schlosser G; Adamo G; Bongiovanni A; Trepiccione F; Guescini M; Pocsfalvi G
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-Coated Extracellular Vesicles for Selective Codelivery of Chemotherapeutics and siRNA to Cancer Cells.
    Jhan YY; Palou Zuniga G; Singh KA; Gaharwar AK; Alge DL; Bishop CJ
    ACS Appl Bio Mater; 2021 Feb; 4(2):1294-1306. PubMed ID: 35014481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine.
    Ilahibaks NF; Lei Z; Mol EA; Deshantri AK; Jiang L; Schiffelers RM; Vader P; Sluijter JPG
    Cells; 2019 Nov; 8(12):. PubMed ID: 31775322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer.
    Sadreddini S; Safaralizadeh R; Baradaran B; Aghebati-Maleki L; Hosseinpour-Feizi MA; Shanehbandi D; Jadidi-Niaragh F; Sadreddini S; Kafil HS; Younesi V; Yousefi M
    Immunol Lett; 2017 Jan; 181():79-86. PubMed ID: 27916629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
    Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
    Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.
    Lamichhane TN; Raiker RS; Jay SM
    Mol Pharm; 2015 Oct; 12(10):3650-7. PubMed ID: 26376343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells.
    Draguet F; Dubois N; Bouland C; Pieters K; Bron D; Meuleman N; Stamatopoulos B; Lagneaux L
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.